The DIPG DMG National Brain Tumor Board recommends using insight from the MRI, clinical notes and the reports from biopsy or liquid biopsy to inform the treating provider as to those clinical trials a patient would not likely be eligible to enter.  The DIPG DMG National Brain Tumor Board will issue a written report to the provider discussing those clinical trials of DIPG DMG and any protocols which may prove to benefit the patient. The status of clinical trials is constantly changing. The DIPG DMG National Brain Tumor Board, through its coordinator, strives to update the tumor board on the satus of available trials.  This allows the board to consider options available across the country which may be suited for the patient under review. However, working together with committed researchers and providers, we believe a better future for those with DIPG/DMG is within reach. To submit a patient for DIPG DMG National Brain Tumor Board review complete this intake form or if you are a provider email DMGNationalTumorBoard@ucsf.edu